MUNJAL PATEL: Open Payments
NPI 1962866624 · FONTANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 39 payments from 8 companies in 2025. Trend: 2023 $618 · 2024 $1,171 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $318 |
| E.R. Squibb & Sons, L.L.C. | 9 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $190 |
| Alkermes, Inc. | 6 | $148 |
| Janssen Pharmaceuticals, Inc | 2 | $68 |
| Lundbeck LLC | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Corium, LLC | 1 | $20 |
Products named: VRAYLAR, COBENFY, CAPLYTA, ARISTADA, INVEGA SUSTENNA, REXULTI, HETLIOZ, Azstarys.
Industry payments across CA — which companies pay providers there.
